(PharmaNewsWire.Com, September 10, 2018 ) The Global market for Neurovascular Intervention is projected to reach nearly US$4 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.
Market growth can be attributed to factors such as rising prevalence of cerebrovascular disease and its associated risk factors, rise in the number of aging population, increasing knowledge of the symptoms of aneurysms and related diseases among patients, next generation of device platforms enters the market, long-term clinical data become available, appropriate treatment guidelines and reimbursement rates are established. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the market. High cost of treatment, unmet needs, scarcity of skilled neurosurgeons is restraining the growth of neurovascular interventional market.
United States is seen as the dominant player in the neurovascular intervention market. Emerging economies of India, China and Japan in the Asia-Pacific region and Latin American countries such as Brazil is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, gross domestic product (GDP) and increasing government investment.
Based on Company, the global neurovascular intervention market can be segmented as follows: Stryker Medtronic MicroVention (Terumo Corporation) De Puy Synthes
Purchase Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-DPI-HnM-3108/ (Priced at USD 1190) On the basis of device, Coil represented the largest single category of products and accounted for XX% share in 2015. However, growth rate has slowed down in the segment which is being challenged by the emerging Carotid Stent, Microwire/Catheter and Clot Removal device. These three major devices grabbed the market share of XX% in 2015. It is expected that Coil will lead the neurovascular intervention market with XX% market share by the end of 2021. Further, prudent analysis has been done on the competitors part, where four major players grab XX% of the global market by revenue. Stryker, Medtronic, Terumo, and DePuy Synthes are the key influencers with their products in the Neurovascular Intervention market. New releases, merger & acquisitions, collaborations and extending distribution networks are few important factors for their dominance.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industryvalidated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, diseases, geographies, companies, price trend, pipeline products, type of devices and competitive landscape. The report concludes with the profiles of major players in the global neurovascular intervention market such as Stryker, Medtronic, Terumo, and DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of neurovascular intervention segment from 2012 to 2021. The report also entails major drivers and challenges of neurovascular intervention market.
The report covers indepth analysis on: Market Segments Market Dynamics Historical Actual Market Size, 2009 2015 Market Size & Forecast 2016 to 2021 Competition & Companies involved Merger & Acquisitions Price Trend Pipeline Products Analysis Market Growth Drivers and Challenges
Neurovascular Intervention Market: Segmentation
Neurovascular Interventional market is classified on the basis of device type, disease type, company and geography.
Based on Device, the global neurovascular intervention market can be segmented as follows:
Based on Geography, the global neurovascular intervention market can be segmented as follows: United States France Germany Italy Spain United Kingdom Japan China India Brazil
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
